SAIMSARA Journal

Machine-Readable Science • ISSN 3054-3991

Carbon Dioxide CO2 Angiography for Kidney-Sparing Vascular Imaging and Interventions: Scoping Review with ☸️SAIMSARA.

Cardiac & Vascular Health icon

Cardiac & Vascular Health

Issue 1, Volume 1, 2026

DOI: 10.62487/saimsara565e9b06

Editorial note
• Last update: 2026-06-02 08:06:28
What is this paper about
CO2 angiography is not simply an “iodine-free alternative,” but a selective kidney-sparing imaging strategy with strongest value in CKD, contrast allergy, dialysis access, peripheral interventions, renal procedures, and EVAR. The full read clarifies where CO2 truly helps, where image quality fails—especially below the knee—and which rare but severe complications demand careful technique and patient selection.
Human-verified editorial review Verified by World ID proof-of-human. This editorial layer was submitted from a SAIMSARA account verified as a unique human.


Generated with SAIMSARA v4.9

Abstract: To characterize the clinical uses, diagnostic and procedural performance, safety profile, technical refinements, and research gaps of CO2 angiography across human, animal, phantom, and bench-based original studies. The review uses 93 references and builds its evidence map from 105 original studies with 4202 total participants/sample observations (topic-deduplicated ΣN). This scoping review indicates that CO2 angiography supports a role as a context-dependent, kidney-sparing and allergy-avoiding contrast strategy rather than a universal substitute for iodinated contrast. The most consistent signal is benefit in renal-vulnerable or iodine-allergic patients undergoing peripheral, renal, dialysis-access, and EVAR procedures, exemplified by large series showing no significant renal-function impact across 1007 CO2 DSA procedures and reduction of iodinated contrast from 148 mL to 27 mL in azotemic EVAR. This utility is tempered by recurrent limitations in distal lower-limb image quality, patient discomfort, and rare but severe ischemic complications. Future work should prioritize prospective comparative trials with standardized safety and image-quality endpoints, particularly benchmarking optimized CO2 delivery against non-contrast MRA for below-knee territories, to clarify where CO2 angiography offers durable clinical advantage.

Keywords: Carbon dioxide angiography; Digital subtraction angiography; Peripheral arterial disease; Chronic kidney disease; Iodinated contrast; Contrast-induced nephropathy; Endovascular therapy; Renal angioplasty; Image quality; Vascular complications

Review Stats

Get access to the full paper

Unlock the full evidence map

Full paper access includes the complete human-readable review, figures, reference index, PDF export, and machine-readable Evidence JSON download.
Evidence JSON can also be purchased separately if you only need the LLM-ready object for agent, AI, or RAG workflows.
Institutional or library access? Sign in with your institution email to open all available SAIMSARA papers under your institution access arrangement.
Need a SAIMSARA review on your own topic? ☸️Request.

Reference Index (93)

Unlock the full paper to view the complete Reference Index.